Recruiting COPD Studies in St Louis
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Interstitial lung disease (ILD) is a lung condition resulting in inflammation and stiffening of the lung, often associated with connective tissue diseases (CTDs). ILD causes reduction in lung volume, ...
Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)
The purpose of this study is to determine if doxycycline will reduce progression of emphysema in people living with HIV. The secondary objectives are to examine the effects of doxycycline on change i...
About COPD Clinical Trials in St Louis
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that makes breathing difficult, primarily caused by smoking. It includes emphysema and chronic bronchitis. Treatment involves bronchodilators, inhaled steroids, pulmonary rehabilitation, and oxygen therapy.
There are currently 2 copd clinical trials recruiting participants in St Louis, MISSOURI. These studies are seeking a combined 690 participants. Research is being sponsored by GlaxoSmithKline, Weill Medical College of Cornell University. Clinical trial participation is free and participants receive study-related medical care at no cost.
COPD Clinical Trials in St Louis — FAQ
Are there copd clinical trials in St Louis?
Yes, there are 2 copd clinical trials currently recruiting in St Louis, MISSOURI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in St Louis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St Louis research site will contact you about next steps.
Are clinical trials in St Louis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St Louis studies also compensate for your time and travel.
What copd treatments are being tested?
The 2 active trials in St Louis are testing new therapies including novel drugs, biologics, and treatment approaches for copd.
Data updated March 2, 2026 from ClinicalTrials.gov